Running head: PTSD IN VETERANS 1
Pharmacologic Interventions VS. Therapy for Veteran’s with Post- Traumatic Stress Disorder
Regina C. Gibbs
Liberty University
PTSD IN VETERANS 2
Did you know that as many as 500,000 veterans who have served in wars over the past 13 years
have been diagnosed with Post-Traumatic Stress Disorder (PTSD) (Reisman, 2016)? While
PTSD is not limited to military veterans, it has been found to have a high prevalence in this
particular community. Reisman (2016, p. 18) describes PTSD as “the development of
characteristic and persistent symptoms along with difficulty functioning after exposure to a life
threatening experience or to an event that either involves a threat to life or serious injury.” The
defenders of our country, and others, are risking not only their lives but also their sanity in order
to keep citizens safe. This research study aims to identify the most beneficial long term treatment
for our heroes.
Significance
War is an element of life that has occurred on this earth since the beginning of time. It goes
without saying that war has a lasting effect on communities and the world as a whole. However,
it also has a large impact on veterans and their family members. We are just now beginning to
understand the lasting effects that war has on an individual and their families. PTSD is an
extremely common anxiety disorder that many veterans suffer from. The core symptoms of
PTSD include re-experiencing traumatic content, persistent avoidance of traumatic content,
negative alterations in cognitions and arousal and reactivity (Haagen, 2015). Many of our
veterans are suffering alone in silence. In many cases, an individual is not even aware that they
are suffering from this disorder. In the United States, 20% of suicides are performed by veterans
(Reisman, 2016). It is incredibly important that we give a voice to those in need. The bible says,
“Speak up for those who cannot speak for themselves, for the rights of all who are destitute.
Speak up and judge fairly; defend the rights of the poor and needy. (Proverbs 31:8-9). It is our
responsibility to find help for our heroes. The best way that we can help these veterans is to find
PTSD IN VETERANS 3
a lasting treatment for their PTSD. With significant research, we can find a way to help integrate
our veterans back into society and give them back the life they once had. Not only will they
benefit, but their families will as well.
Research Question
With all of this being said, it is important to determine the best way to treat our veterans. In
veterans with Post-Traumatic Stress Disorder, are pharmacologic interventions more effective
than therapy in sustaining the service member’s transition back to society after five years of
returning home? Is it more beneficial for veterans to receive medication or therapy to help them
adjust back into their lives at home after their traumatic experiences?
There are many medications used to help control the symptoms of PTSD. However, with those
medications come multiple side effects. Fortunately, those side effects can also be treated with
more medications. The cycle continues until the veteran is essentially a walking pharmacy.
“Psychopharmacologic treatment of PTSD is primarily symptomatic and encompasses agents
from all categories of centrally acting drugs” (Birkhimer, 2004). The only problem is, you’re not
actually treating the PTSD, and you’re just controlling the symptoms. The root of the problem is
still there.
Hypothesis
Psychological therapies are more effective in treating veterans with PTSD than pharmacologic
interventions after five years. With CBT, patients are able to use redirect destructive thoughts and
develop personal coping skills without the side effects of multiple medications. The
independent variables in this study will be the medications the veterans receive and CBT. The
dependent variable will be the veteran’s ability to integrate themselves back into society. The
PTSD IN VETERANS 4
main goal is to establish a treatment that will help veterans transition back to a normal life and
society after experiencing trauma and suffering from PTSD.
Literature Review
This section will begin by covering the risk factors for PTSD among veterans. Then
research concerning treatment options for these individuals will be reviewed. Lastly, veteran
satisfaction and treatment preferences will be discussed.
Risk Factors
In order to thoroughly treat veterans with PTSD it is important to identify those individuals who
are at risk. While anyone can suffer from PTSD for various reasons, some individuals have a
higher chance of developing this disorder. Some people are able to cope with a higher level of
trauma than others. Xue collected data from 32 different studies to help identify risk factors of
PTSD in veterans. The sample sizes of these studies ranged from 238 to 40,600 (Xue, et al.,
2015). This study breaks down the risk factors found into three groups including: pre trauma
factors, peri-trauma factors and post-trauma factors. The study concluded that the highest
predictor was peri-trauma factors, trauma severity, and adverse life events (Xue et al., 2015).
Peri-trauma factors for veterans include but are not limited to, seeing someone wounded or
killed, injuries to themselves, and firing weapons. Factors such as race and age were originally
thought to play a higher significance in regards to PTSD. However, studies show that they are
unrelated.
When discussing military characteristics it was determined that military rank, occupation, and
length and number of deployments plays a very critical role in developing PTSD (Xue et
al.,2015). Enlisted members of the military are more likely to experience combat than officers in
PTSD IN VETERANS 5
the military. Therefore, enlisted veterans have a higher chance of developing PTSD compared to
officers. Enlisted members are also usually left to do grunt work which can potentially lead to
feelings of depression and negativity. Occupation also played a large role in contributing to
PTSD development. It seems fair to say that an infantry man will see more combat than a
military cook. However, it is important to note that anyone in the military can experience
combat and they are all trained to fight. In reality though, infantry men and other combat related
billets will experience more traumatic events than someone that is not in a combat related billet.
The length of time and number of deployments is also a contributing factor. If a veteran is
deployed multiple times over the course of a few years he has a greater chance of being exposed
to trauma than someone that isn’t deployed often. It is also important to take into consideration
the veteran’s personal life. It is possible that veterans are missing important events in their home
life including the birth of a child, the death of a family member, or their best friend’s wedding.
These circumstances are very likely to weigh heavy on an individual’s mind and potential
leading to feelings of sadness. In this case, if a traumatic event did occur it is possible that the
event compiled with their sadness about life situations can lead to PTSD. It has been concluded
from this article that the most attention should be given to the role of personnel and environment
variables in predicting PTSD (Xue et al., 2015).
Treatment Options
There are numerous treatments available for PTSD so it would be beneficial to determine which
are the most effective in veterans. Sharpless and Barber (2011) evaluated psychological and
pharmacological approaches to PTSD in veterans. Psychotherapies such as Prolonged Exposure
(PE), Cognitive Processing Therapy (CPT) and Eye Movement Desensitization and Reprocessing
(EMDR) were found to be the most effective in treating veterans. Relaxation training and stress
PTSD IN VETERANS 6
inoculation training were found to be far less effective (Sharpless & Barber, 2011). PE utilizes
imaginal exposure, processing of imaginal exposure, and relaxation training focused on slow
breathing techniques. Sessions are conducted over an 8-15 week period and each session lasts 90
minutes (Sharpless & Barber, 2011). CPT involves 12 weekly, 60 minute, individual sessions.
The goal is to reduce PTSD through emotional processing and cognitive restructuring of trauma-
related emotions and thoughts (Schumm, Walter, Bartone, & Chad, 2015). This form of
treatment is more intense than others. EDMR attempts to use desensitization and reprocessing by
having the veteran imagine distressing images while tracking finger movements by the therapist
(Sharpless &Barber, 2011).
Propranolol (Inderal), a beta-adrenergic antagonist (beta-blocker), is the most effective
medication for reducing symptoms of PTSD. In the end authors found that PE is the
psychotherapy of choice. Many studies note that antidepressants such a Zoloft and Paxil are
considered first- line choices in treating PTSD (Schumm, Walter, Bartone, & Chad, 2015). It is
also noted that paroxetine, sertraline and venlafaxine are the most promising medications used to
treat PTSD symptoms (Sharpless & Barber, 2011). It is also important to note that some of these
treatments are based on the veteran’s willingness to participate. Some individuals may not feel
comfortable talking about their experiences and diving into treatment. The veteran’s preferences
can have a large impact on the type of treatment used. Also, different goals can change the
treatment. Some goals include just symptom relief while other want to dissect what needs to be
done to improve relationships and quality of life. Some beneficial treatments may not be utilized
if individuals don’t see the value in that particular option (Schumm, Walter, Bartone, & Chad,
2015). Many individuals do not like the idea of taking medications and would prefer to be
involved in psychotherapy. Schumm (2015) conducted a study determining that veterans most
PTSD IN VETERANS 7
frequently endorse a preference for psychotherapy versus medication when addressing PTSD.
The most popular psychotherapy was CPT and PE.
In light of studies reviewed, there is a need to conduct further studies that determine why
veterans prefer each specific type of treatment. Is there a preference that is more desirable based
on age, race, or gender? Secondly, more research should be conducted on which treatment is
more suitable for long term results. It is possible that some treatments are able to get the patient
through the initial diagnosis of PTSD, but are not beneficial in maintaining results. The goal is to
determine which treatment option will have the most beneficial results for the veteran over the
longest period of time.
Study Setting
This research study will be conducted at a military hospital on the north east coast of the United
States of America. This facility provides care to every branch of the military. Many of the
patients at this facility have experience trauma from combat while serving in the military. It is
one of the largest military hospitals, and also the only joint operations hospital for military
members in the US.
All participants will be outpatient as opposed to inpatient. It is ideal to know how the
patient will act in society during the treatment. Therapeutic services will be held in the
behavioral health clinic of the hospital. The study will be conducted on military veterans
experiencing high levels of PTSD related to combat.
Research Design
The type of design that will be used in this study is the experimental design. The
experimental design is a type of quantitative research. One of the purposes of experimental
PTSD IN VETERANS 8
research is to test a null hypothesis by applying an intervention to the experimental subjects but
not to the control subject, and then measuring the effect on a dependent variable (Gray, Grove, &
Sutherland, 2017, p. 38). This is the exact type of research needed for this study. This particular
study will have two independent variables. The first independent group will receive medications
common for treating PTSD such as Propranolol, but will not receive therapy of any kind. The
next independent group will receive therapeutic services including CBT, EMDR, and PE. The
control group will not be given any type of treatment, but they will be given a placebo
medication.
Sample and Sampling Procedure
For this research study, a random sample will be obtained. All subjects will be volunteers from
the joint command military outpatient behavioral health clinic. There will be 150 participants in
this study. Of those, 50 subjects will be part of the independent groups and 50 subjects for the
control group. It would be ideal to have 75 subjects be male and 75 female. This particular study
will not use any veterans that are struggling with gender issues. Often times, individuals that
have gender issues also suffer from other psychiatric issues. Depression, suicidal ideation,
interpersonal trauma exposure, substance abuse, anxiety and general distress are all consistently
elevated among transgender and gender non-conforming individuals (Valentine & Shipher,
2018). We want to ensure that all psychiatric issues and trauma are related to combat received
from military service.
All of the participants in this study will be military members that are no longer serving. While
there are plenty of military members that live in the US, it is very apparent that service members
are part of a unique culture. Being in the military is drastically different than being a normal
member of society. With this being said, it requires a different set of coping skills to integrate
PTSD IN VETERANS 9
back into society than it does when staying in the military. This study aims to find a treatment for
veterans returning back to society. Unfortunately, this study will be excluding active military
service members and service members that are part of a Reserves unit.
The participants will range in age from 18-35. Socioeconomic status, ethnicity, and marital status
will not be a factor when determining candidates. All participants will have been discharged
from the military within one year of when the study occurs. Also, each participant has to have
PTSD associated with combat trauma. The combat trauma needs to have occurred within two
years of when the subjects begin the study. Participants can be from any branch of the military
as long as they have experienced combat trauma within two years.
The study will randomly select 150 volunteers that meet all of the criteria. The 150
candidates will be randomly inserted into each group. There will be equal numbers of males and
females in each group. The participants will be unaware of the specific group they are placed in.
Ethical Issues
As with anything, there are potential ethical issues that may arise. With this particular study, it
could be questioned whether or not it is ethical to not include individuals suffering from gender
issues. Just because they have these issues does not mean that they haven’t also experience
PTSD related to combat trauma. There are many transgender individuals that don’t suffer from
any psychological trauma based off of their sexuality. Is it ethical to not include these individuals
in the study? For the purposes of this study, transgender individuals will not be included because
it is important that the study is not tampered with by any extenuating circumstances.
In order to protect the participant’s rights and privacy, the study will follow the Health
Insurance Portability and Accountability Act (HIPAA) of 1966. HIPAA is a federal legislation
PTSD IN VETERANS 10
that aims to ensure the privacy of a patient’s healthcare information (Houston, 2009). Each
participant will have an individual record that is kept in a locked file that only direct members of
their medical team can access. The facilitators of this study will have training on confidentiality.
With this study, we are potentially risking veteran’s not receiving treatment at all. There
will be 50 individuals that are only receiving a placebo. However, placebos have been found to
cause clinically relevant changes and are sometimes indistinguishable from what they are being
tested against (Gaab, 2018). This could potentially not be the case and some individuals may
actually experience worse symptoms of PTSD. We are also potentially not giving a participant
that is more suitable for pharmacologic treatment the correct treatment if they are a part of the
therapy group. This is also the same vice versa. If a patient is more suitable to therapy and they
are only receiving medication, it could be a potential risk. However, with great risk comes great
reward.
Data Collection
In order to collect data, this research study will use interviews to gather information. The
study will take place over a one year time frame. Every month, participants will have a one on
one interview for one hour. Each participant will have twelve interviews in total resulting in 120
hours of interviews.
During the interview, participants will be able to discuss their progress. While there will be
a list of standardized questions ( see Appendix A), participants are free to discuss any issues that
are pressing to them. They may discuss their doubts and concerns. The goal is to make the
participant feel as supported as possible during this study. In order to do so, the same
interviewer will interview the same participant during all twelve sessions. This will help with
PTSD IN VETERANS 11
the continuity of care and accuracy of the results. The interviewer and the participant will be
able to build a strong and trusting relationship.
It is important that the interview process is not confused with a therapy session. While it
may be therapeutic for the participant to vent to someone, this session is not for advice. The
interviewer will not give the participant any advice or change the plan of care in any way. The
interview is strictly for gaining information on the progress of the participant. The interviewer
will have a specific set of questions that the participant can expound on. They are there to get a
generalized picture of whether or not the prescribed treatment for the participant is being
helpful.
Data Analysis
In this study, analysis of variance (ANOVA) is the procedure that will be used in order to
analyze data. This procedure compares data between two or more groups to investigate the
differences between those groups (Gray, Grove, & Sutherland, 2017, p. 571). There are two
treatment groups and one dependent group in this study. During each interview, the interviewer
will give the participant a score based off of their questionnaire. The variances in the
participant’s scores from the beginning of the study until the end will be used to analyze data.
Strengths and Weaknesses
A strength of this study is the amount of participants being examined. With 150 participants
the size is large enough to solidly analyze data. Using males and females in the study is another
strength. We are able to get a generalized idea of the impact that medications and therapy will
have on both genders. However, in the future it may be beneficial to conduct a study with just
PTSD IN VETERANS 12
males and just females. This may give a better idea on what treatment works best on each
gender.
Another strength of this study is the collection method. It will be incredibly beneficial to
directly observe the progress or lack of progress of the participants in such an intimate manner.
This study could have collected measurements from charts and files, but instead chose to sit
down and interview each participant. This will give the best grasp on evaluating the
information.
A weakness of this study could potentially be the financial cost. It is imperative that the
financial responsibilities are evaluated in order to actually conduct the study. The location of the
interviews, the interviewers, and all other participants will need to be compensated.
Another weakness is potentially having participants drop out of the study. It is important
that each participant remains a part of the study until completion. It is also imperative that each
participant is honest about their progress and concerns. If they are not honest during the
questionnaire it could potentially be detrimental to the data analysis.
This study will be incredibly beneficial for veterans. However, in the future it would be
beneficial to have a study that examines the family members of a veteran with PTSD. Which
treatment do they feel is the most effective for the family member with PTSD? How are these
treatments and results affecting the life of their loved ones? This particular study is lacking any
information on this subject. It is recommended that treatment for PTSD include support of the
family for military personnel suffering while healing from trauma (Ray & Vanstone, 2009).
Unfortunately, this study will not include family members in any way.
PTSD IN VETERANS 13
While this study will provide great information for PTSD treatment for veterans there are
still weaknesses in the study. An area that is potentially lacking in this research is long term
outcomes. It is possible that the treatment may provide immediate relief from PTSD, but what
about in the future? Will the same treatment still work for the patient 20 years from now?
In summary, this study will be incredibly beneficial to veteran’s who are suffering from
PTSD. A superior treatment will be identified that will make the transition back into society more
manageable for our veterans with PTSD.
PTSD IN VETERANS 14
References
Birkhimer, L. J., Devane, L. C., & Muniz, C. E. (2004, April 06). Posttraumatic stress disorder:
Characteristics and pharmacological response in the veteran population. Retrieved
from Posttraumatic stress disorder: Characteristics and pharmacological response in the
veteran population
Gaab, J. (2018, August 03). The placebo and its effects: A psychoneuroendocrinological
perspective. Retrieved from The placebo and its effects: A psychoneuroendocrinological
perspective https://www.sciencedirect.com/science/article/pii/S0306453018305705
Gray, J., Grove, S. K., & Sutherland, S. (2017). Burns and Groves the practice of nursing
research appraisal, synthesis, and generation of evidence. St. Louis, MO: Elsevier.
Haagen, J. F., Smid, G. E., Knipscheer, J. W., & Kleber, R. J. (2015, June 27). The efficacy of
recommended treatments for veterans with PTSD: A metaregression analysis. Retrieved
from The efficacy of recommended treatments for veterans with PTSD: A metaregression
analysis
Houston, M. (2009, November 29). The psychiatric medical record, HIPAA, and the use of
electronic medical records. Retrieved from The Psychiatric Medical Record, HIPAA, and
the Use of Electronic Medical Records
https://www.sciencedirect.com/science/article/pii/S1056499309000911
PTSD IN VETERANS 15
Ray, S. L., & Vanstone, M. (2009, February 07). The impact of PTSD on veterans' family
relationships: An interpretative phenomenological inquiry. Retrieved from
https://www.sciencedirect.com/science/article/pii/S0020748909000066
Reisman, M. (2016, October). PTSD treatment for veterans: what's working, what's new, and
what's next. Retrieved March 28, 2019, from PTSD Treatment for Veterans: What’s
Working, What’s New, and What’s Next
Schumm, J. A., Walter, K. H., Bartone, A. S., & Chard, K. M. (2015, April 16). Veteran
satisfaction and treatment preferences in response to a posttraumatic stress disorder
specialty clinic orientation group. Retrieved from
https://www.sciencedirect.com/science/article/pii/S0005796715000649
Sharpless, B. A., & Barber, J. P. (2011). A clinician's guide to PTSD treatments for returning
veterans. Professional Psychology: Research and Practice, 42(1), 8-
15. http://dx.doi.org/10.1037/a0022351
Valentine, S. E., & Shipherd, J. C. (2018, March 28). A systematic review of social stress and
mental health among transgender and gender non-conforming people in the United States.
Retrieved from A systematic review of social stress and mental health among transgender
and gender non-conforming people in the United States
https://www.sciencedirect.com/science/article/pii/S0272735817304208
Xue, C., Ge, Y., Tang, B., Liu, Y., Kang, P., Wang, M., & Zhang, L. (2015, March 20). A meta-
analysis of risk factors for combat-related PTSD among military personnel and veterans.
Retrieved from A Meta-Analysis of Risk Factors for Combat-Related PTSD among
Military Personnel and Veterans
PTSD IN VETERANS 16
Appendix A
Progress Questionnaire for Veteran’s With PTSD
1. The number of nightmares I have had this month have decreased.
Stongly Disagree Disagree Indifferent Agree Strongly Agree
Why:
______________________________________________________________________________
______________________________________________________________________________
2. The amount of outbursts I have had this month have decreased.
Stongly Disagree Disagree Indifferent Agree Strongly Agree
Why:
______________________________________________________________________________
______________________________________________________________________________
3. My relationships with family and friends have improved.
Stongly Disagree Disagree Indifferent Agree Strongly Agree
Why:
______________________________________________________________________________
______________________________________________________________________________
4. I am successfully able to control my emotions and redirect my thoughts.
Stongly Disagree Disagree Indifferent Agree Strongly Agree
Why:
______________________________________________________________________________
______________________________________________________________________________
5. I feel that my treatment method is benefiting me in a positive way.
Stongly Disagree Disagree Indifferent Agree Strongly Agree
PTSD IN VETERANS 17
Why:
______________________________________________________________________________
______________________________________________________________________________
6. Please discuss any of your thoughts and concerns with interviewer.